Researchers have identified a promising new strategy to treat autoimmune diseases by targeting a specific molecular interaction within immune cells.
Morning Overview on MSN
Sepsis target emerges as chloride channel PACC1 boosts bacteria killing
Every year, sepsis kills roughly 11 million people worldwide, more than lung cancer and heart attacks combined. Despite ...
Au Royaume-Uni, des chercheurs ont cartographié pour la première fois un médicament dans des tumeurs d’ovaire humaines et ...
Scientists developed a new class of compounds that block the interaction between Munc13-4 and syntaxin 7. The approach ...
A new class of drug compounds, called ENDOtollins, reduce harmful inflammation while maintaining the body’s ability to fight infections.
Alzheimer’s disease is one of the most serious brain disorders in the world today. It slowly damages memory, thinking, and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results